Found 163 chains in Genus chains table. Displaying 1 - 50. Applied filters: Proteins

Search results query: isomerase/isomerase inhibitor

Total Genus Sequence Length pdb Title
28 108 7u8dA Fkbp12 mutant v55g bound to rapa*-3z
49 163 7tguX Structure of cyclophilin d peptidyl-prolyl isomerase domain bound to macrocyclic inhibitor b1
51 163 7thfA Structure of cyclophilin d peptidyl-prolyl isomerase domain bound to macrocyclic inhibitor b53
53 164 7tgvX Structure of cyclophilin d peptidyl-prolyl isomerase domain bound to macrocyclic inhibitor b2
131 357 7mqxA P. putida mandelate racemase forms an oxobenzoxaborole adduct with 2-formylphenylboronic acid
48 158 6vajA Crystal structure analysis of human pin1
51 165 6x4qA Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: (2r,5s,11s,14s,18e)-14-cyclobutyl-2,11,17,17-tetramethyl-15-oxa-3,9,12,26,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(25),18,20(28),21,23,26-hexaene-4,10,13,16-tetrone (compound 33)
55 165 6x4pA Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: (2r,5s,11s,14s,18e)-2,11,17,17-tetramethyl-14-(propan-2-yl)-15-oxa-3,9,12,26,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(25),18,20(28),21,23,26-hexaene-4,10,13,16-tetrone (compound 28)
52 167 6x4mA Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: tert-butyl [(2s)-1-{[(3s,17s)-2,16-dioxo-10,15-dioxa-1,21-diazatricyclo[15.3.1.1~5,9~]docosa-5(22),6,8-trien-3-yl]amino}-3-methyl-1-oxobutan-2-yl]carbamate (compound 3)
51 163 6x4oA Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: (2r,5s,11s,14s,18e)-2,11-dimethyl-14-(propan-2-yl)-3-oxa-9,12,15,21,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(26),18,20,22,24,27-hexaene-4,10,13,16-tetrone (compound 21)
49 165 6x4nA Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors: (2r,5s,11s,14s,18e)-2,11,17,17-tetramethyl-14-(propan-2-yl)-3-oxa-9,12,15,26,29-pentaazatetracyclo[18.5.3.1~5,9~.0~23,27~]nonacosa-1(25),18,20(28),21,23,26-hexaene-4,10,13,16-tetrone (compound 24)
54 163 6x3rA Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors
51 166 6x3yA Human cyclophilin a bound to a series of acylcic and macrocyclic inhibitors
97 297 6p13B Structure of spastin aaa domain (t692a mutant) in complex with a diaminotriazole-based inhibitor (crystal form a)
91 296 6p11B Structure of spastin aaa domain (t692a mutant) in complex with jnj-7706621 inhibitor
97 296 6p12B Structure of spastin aaa domain (wild-type) in complex with diaminotriazole-based inhibitor
94 300 6p14A Structure of spastin aaa domain (t692a mutant) in complex with a diaminotriazole-based inhibitor (crystal form b)
93 296 6p10B Structure of spastin aaa domain (n527c mutant) in complex with jnj-7706621 inhibitor
65 148 5k0iA Mpges1 bound to an inhibitor
34 114 5hvtA Crystal structure of macrophage migration inhibitory factor (mif) with a potent inhibitor (nvs-2)
34 114 5hvsA Crystal structure of macrophage migration inhibitory factor (mif) with a biaryltriazole inhibitor (3i-305)
34 114 6cb5A Macrophage migration inhibitory factor in complex with a pyrazole inhibitor (8g)
35 114 6b1kA Macrophage migration inhibitory factor in complex with a naphthyridinone inhibitor (3a)
36 114 6b1cA Macrophage migration inhibitory factor in complex with a naphthyridinone inhibitor (4a)
31 114 6b2cA Macrophage migration inhibitory factor in complex with a naphthyridinone inhibitor (4b)
58 210 5bodA Crystal structure of streptococcus pneumonia pare inhibitor
66 148 5bqiA Discovery of a potent and selective mpges-1 inhibitor for the treatment of pain
64 148 5bqhA Discovery of a potent and selective mpges-1 inhibitor for the treatment of pain
31 113 4z15A Mif in complex with 3-(2-furylmethyl)-2-thioxo-1,3-thiazolan-4-one
31 113 4z1uA Mif in complex with 1-(4-methylphenyl)-3-phenylprop-2-yn-1-one
32 113 4z1tA Mif in complex with 4-[(4-oxo-2-thioxo-1,3-thiazolan-3-yl)methyl]benzonitrile
52 164 4totA Crystal structure of rat cyclophilin d in complex with a potent nonimmunosuppressive inhibitor
34 114 4f2kA Macrophage migration inhibitory factor covalently complexed with phenethylisothiocyanate
70 198 4edzA Crystal structure of hh-pgds with water displacing inhibitor
73 198 4edyA Crystal structure of hh-pgds with water displacing inhibitor
142 388 4duoA Room-temperature x-ray structure of d-xylose isomerase in complex with 2mg2+ ions and xylitol at ph 7.7
57 210 4em7A Crystal structure of a topoisomerase atp inhibitor
56 203 4duhA Crystal structure of 24 kda domain of e. coli dna gyrase b in complex with small molecule inhibitor
73 199 4ec0A Crystal structure of hh-pgds with water displacing inhibitor
71 198 4ee0A Crystal structure of hh-pgds with water displacing inhibitor
57 210 4emvA Crystal structure of a topoisomerase atp inhibitor
35 114 3wntA Multiple binding modes of benzyl isothiocyanate inhibitor complexed with macrophage migration inhibitory factor
34 114 3wnsA Allyl isothiocyanate inhibitor complexed with macrophage migration inhibitory factor
35 114 3wnrA Multiple binding modes of benzyl isothiocyanate inhibitor complexed with macrophage migration inhibitory factor
68 198 3vi5A Human hematopoietic prostaglandin d synthase inhibitor complex structures
75 198 3vi7A Human hematopoietic prostaglandin d synthase inhibitor complex structures
63 194 3u2dA S. aureus gyrb atpase domain in complex with small molecule inhibitor
62 194 3ttzA Crystal structure of a topoisomerase atpase inhibitor
64 194 3u2kA S. aureus gyrb atpase domain in complex with a small molecule inhibitor
47 157 3tc5A Selective targeting of disease-relevant protein binding domains by o-phosphorylated natural product derivatives